Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Com Stk Usd0.01 [Di] (MXCT.LN)

Com Stk Usd0.01 [Di] (MXCT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results Globe Newswire - Wed Aug 10, 2022

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md.,...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022 Globe Newswire - Fri Jul 15, 2022

GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Fri May 13, 2022

GAITHERSBURG, Md., May 13, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte Reports First Quarter Financial Results Globe Newswire - Mon May 9, 2022

MaxCyte Increases 2022 Core Revenue Growth Guidance to be at least 25% and Reiterates Milestone Revenue Guidance of $4 million...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte to Participate in Upcoming Investor Conferences Globe Newswire - Tue May 3, 2022

GAITHERSBURG, Md., May 03, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022 Globe Newswire - Wed Apr 20, 2022

GAITHERSBURG, Md., April 20, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Fri Apr 15, 2022

GAITHERSBURG, Md., April 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a leading commercial cell-engineering company...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte Announces Departure of CFO and Appointment of Ron Holtz as Interim CFO, Announces Preliminary First Quarter 2022 Revenue Globe Newswire - Tue Apr 12, 2022

GAITHERSBURG, Md., April 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte Reports Fourth Quarter and Full Year Financial Results Globe Newswire - Tue Mar 22, 2022

MaxCyte Provides Initial 2022 Guidance...

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer Globe Newswire - Wed Mar 9, 2022

Dr. Sumen brings extensive experience in scientific and technology evaluation, process development and leadership....

MXCT : 4.80 (+5.73%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 360.000 (-0.28%)

Barchart Exclusives

Unusual Options Volume Greets e.l.f. Beauty (ELF) Stock Post Earnings Barchart - 45 minutes ago
Following a standout earnings performance, ELF stock appears poised for even more upside thanks to compelling and supportive fundamentals. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot